GRAIL Inc. filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders
$GRAL
Medical Specialities
Health Care
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
_____________________________________________
FORM 8-K
_____________________________________________
CURRENT REPORT
Pursuant to Section 13 or 15(d)
of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): May 29, 2025
_____________________________________________
(Exact Name of Registrant as Specified in Charter)
___________________________________________
(State or Other Jurisdiction of Incorporation) | (Commission File Number) | (IRS Employer Identification No.) | ||||||
(Address of Principal Executive Offices) (Zip Code)
Registrant’s telephone number, including area code: (833 ) 694-2553
Not Applicable
(Former Name or Former Address, if Changed Since Last Report)
___________________________________________
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
| Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) | |||||
| Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) | |||||
| Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) | |||||
| Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) | |||||
Securities registered pursuant to Section 12(b) of the Act:
| Title of each class | Trading Symbol(s) | Name of each exchange on which registered | ||||||||||||
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§ 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter).
Emerging growth company ☒
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☒
Item 5.07 | Submission of Matters to a Vote of Security Holders. | ||||
The Annual Meeting of Stockholders (“Annual Meeting”) of GRAIL, Inc. (the “Company”) was held on May 29, 2025. Of the 35,296,858 shares of the Company’s common stock entitled to vote at the Annual Meeting as of the March 31, 2025 record date, 29,682,974 shares were represented at the beginning of the meeting in person or by proxy, constituting a quorum. The following are voting results for the proposals considered and voted upon at the Annual Meeting, each of which were described in the Company’s Definitive Proxy Statement filed with the Securities and Exchange Commission on April 15, 2025.
Proposal 1: The Company’s stockholders elected one Class I Director to serve until the Annual Meeting of Stockholder to be held in 2028 and until their successor is duly elected and qualified. The votes regarding the election of the director were as follows:
Name | Votes For | Withheld | Broker Non-Votes | |||||||||||||||||
William Chase | 19,046,188 | 1,234,461 | 9,402,325 | |||||||||||||||||
Proposal 2: The Company’s stockholders ratified the selection of Ernst & Young LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2025. The proposal received the following votes:
Votes For | Votes Against | Abstentions | Broker Non-Votes | |||||||||||||||||
| 29,086,225 | 66,878 | 529,871 | 0 | |||||||||||||||||
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
| GRAIL, INC. | ||||||||||||||
| Date: | May 30, 2025 | By: | /s/ Abram Barth | |||||||||||
| Name: | Abram Barth | |||||||||||||
| Title: | General Counsel and Secretary | |||||||||||||